AlphaCentric Advisors LLC — 13F Holdings & Portfolio
CIK 1913464 · latest 13F-HR filed 2026-11-03
AlphaCentric Advisors LLC manages $112.6M in 13F-reported U.S. long-equity assets across 247 reported positions as of its 2026-09-30 13F-HR filing. Its largest disclosed positions are SHY (4.76%), GILD (2.82%), IWD (2.65%). Quarter over quarter (versus its 2026-06-30 filing) the fund opened 34 new positions and exited 48; 85 existing positions rose in reported value and 94 fell.
AUM is the long-equity portion reported on Form 13F-HR. Excludes short positions, cash, foreign holdings, and non-13F assets. For informational purposes only — not investment advice.
Long-equity book
Distinct positions
Filed 2026-11-03
vs 2026-06-30
Portfolio charts
Latest quarter's book, what changed, and how the portfolio has evolved across filings.
Portfolio map
Q3 26Box size = position value; colour = change in share count vs the prior quarter (green added, red trimmed, blue new). Rows split across managers or share classes are combined. Click a box for the stock.
Sector mix
% of 13F valueSectors from each company's SIC code; funds and ETFs grouped separately.
Biggest buys and sells
Q2 26 → Q3 26Estimated from the change in shares held × the quarter-end price, so price moves alone don't count as buying. New and exited positions are included.
13F assets and positions
4 quartersTotal reported 13F value (bars) and number of positions (line) each quarter. Value changes include market moves.
Top positions over time
reported valueThe eight largest current positions, valued at each quarter end.
Concentration
top 10 = 23.4%Cumulative share of the portfolio held in the largest N positions.
As of the firm’s regulatory filing dated Jun 2, 2026.
FLOOR 7, SUITE 2
SAN JUAN, PR 00912
| Name | Title / Status | Ownership | Type |
|---|---|---|---|
| ALPHA PARTNERS LLC Control | MEMBER since Apr 2014 | 25–50% | Domestic Entity |
| GLASS, ROBERT, DAVID Control | CCO since Feb 2015 | Less than 5% | Individual |
| SZILAGYI, JERRY, JOHN Control | MANAGING MEMBER since Apr 2014 | 25–50% | Individual |
| Schoonover, Michael, Thomas Control | MEMBER since Jun 2026 | 5–10% | Individual |
| JERRY J. SZILAGYI 2015 FAMILY TRUST | MEMBER since Dec 2015 | 10–25% | Domestic Entity |
| MILLER, DAVID, SCOTT Control Indirect owner via ALPHA PARTNERS LLC | MEMBER since Jun 2026 | 25–50% | Individual |
| SZILAGYI, ISOBEL, LINDA Indirect owner via JERRY J. SZILAGYI 2015 FAMILY TRUST | TRUSTEE since Dec 2015 | General partner, trustee or manager | Individual |
| Szilagyi, June, Ann Indirect owner via JERRY J. SZILAGYI 2015 FAMILY TRUST | TRUSTEE since Dec 2015 | General partner, trustee or manager | Individual |
Ownership & leadership changes · 8 filings with changes since Apr 9, 2014
From the firm’s regulatory filings, newest first. Dates are filing dates: a filing that no longer lists someone does not say when they left.
- No longer listedKAMIES, MARK, JAMES · MEMBER · 5–10% · control person · listed since Apr 2014
- AddedMILLER, DAVID, SCOTT · MEMBER · 25–50% · indirect via ALPHA PARTNERS LLC · control person
- AddedSchoonover, Michael, Thomas · MEMBER · 5–10% · control person
- No longer listedBETTER OUTCOMES LLC · MEMBER · 25–50% · indirect via ALPHA PARTNERS LLC · listed since Feb 2022
- ChangedGLASS, ROBERT, DAVID · now a control person
- AddedBETTER OUTCOMES LLC · MEMBER · 25–50% · indirect via ALPHA PARTNERS LLC
- ChangedKAMIES, MARK, JAMES · title MANAGING MEMBER → MEMBER
- AddedSZILAGYI, ISOBEL, LINDA · TRUSTEE · General partner, trustee or manager · indirect via JERRY J. SZILAGYI 2015 FAMILY TRUST
- AddedSzilagyi, June, Ann · TRUSTEE · General partner, trustee or manager · indirect via JERRY J. SZILAGYI 2015 FAMILY TRUST
- ChangedJERRY J. SZILAGYI 2015 FAMILY TRUST · title SHAREHOLDER → MEMBER
- AddedJERRY J. SZILAGYI 2015 FAMILY TRUST · SHAREHOLDER · 10–25%
- ChangedSZILAGYI, JERRY, JOHN · ownership 50–75% → 25–50%
- AddedGLASS, ROBERT, DAVID · CCO · Less than 5%
- ChangedKAMIES, MARK, JAMES · now a control person
- ChangedSZILAGYI, JERRY, JOHN · title MANAGING MEMBER AND CCO → MANAGING MEMBER
- ListedALPHA PARTNERS LLC · MEMBER · 25–50% · control person
- ListedKAMIES, MARK, JAMES · MANAGING MEMBER · 5–10%
- ListedSZILAGYI, JERRY, JOHN · MANAGING MEMBER AND CCO · 50–75% · control person
Quarter-over-quarter changes
Changes in reported position value vs the prior 13F, so price moves count too, not just shares bought or sold.
Top Adds (vs prior quarter)
- ISHARES TR$4.3M +403.9%
- ISHARES TR$1.6M +113.0%
- INVESCO EXCHANGE TRADED FD T$1.5M +111.6%
- GILEAD SCIENCES INC$590.9K +22.9%
- CENTERSPACE$535.0K +190.4%
Top Trims
- AEVA TECHNOLOGIES INC-$909.5K -63.3%
- IONIS PHARMACEUTICALS INC-$501.8K -41.0%
- GRAPHIC PACKAGING HLDG CO-$430.4K -90.5%
- SAUL CTRS INC-$406.2K -31.0%
- SIDUS SPACE INC-$381.0K -67.8%
New Positions
- ALPINE INCOME PPTY TR INC$1.3M
- ISHARES TR$950.4K
- ASML HLDG NV$770.0K
- KINIKSA PHARMACEUTICALS INTL$595.9K
- OFFICE PPTYS INCOME TR$477.9K
Exited Positions
- APOGEE THERAPEUTICS INC$1.5M
- INVESCO QQQ TR$1.4M
- INVESCO EXCH TRADED FD TR II$1.4M
- HOWARD HUGHES HOLDINGS INC$1.1M
- SMARTSTOP SELF STORAG REIT I$812.5K
AlphaCentric Advisors LLC Holdings (2026-09-30)
Rows tagged Call or Put are options positions, not stock. Per SEC Form 13F-HR, Value shows the notional value of the underlying (shares covered × underlying price), not the option premium. Shares is the number of underlying shares covered (divide by 100 for contract count).
| # | Issuer | Symbol | CUSIP | Value | Weight | Shares | Type |
|---|---|---|---|---|---|---|---|
| 1 | ISHARES TR | SHY | 464287457 | $5.4M | 4.76% | 66,011 | SH |
| 2 | GILEAD SCIENCES INC | GILD | 375558103 | $3.2M | 2.82% | 21,278 | SH |
| 3 | ISHARES TR | IWD | 464287598 | $3.0M | 2.65% | 12,020 | SH |
| 4 | INVESCO EXCHANGE TRADED FD T | RPV | 46137V258 | $2.9M | 2.59% | 25,447 | SH |
| 5 | VERTEX PHARMACEUTICALS INC | VRTX | 92532F100 | $2.7M | 2.37% | 5,115 | SH |
| 6 | INVITATION HOMES INC | INVH | 46187W107 | $1.9M | 1.71% | 73,000 | SH |
| 7 | ASTRAZENECA PLC | AZN | G0593M107 | $1.9M | 1.70% | 11,866 | SH |
| 8 | ROIVANT SCIENCES LTD | ROIV | G76279101 | $1.8M | 1.64% | 50,535 | SH |
| 9 | INCYTE CORP | INCY | 45337C102 | $1.8M | 1.63% | 15,140 | SH |
| 10 | ARGENX SE | ARGX | 04016X101 | $1.8M | 1.57% | 1,841 | SH |
| 11 | NEUROCRINE BIOSCIENCES INC | NBIX | 64125C109 | $1.5M | 1.29% | 10,230 | SH |
| 12 | EURONET WORLDWIDE INC | EEFT | 298736109 | $1.4M | 1.20% | 21,560 | SH |
| 13 | PROTAGONIST THERAPEUTICS INC | PTGX | 74366E102 | $1.4M | 1.20% | 9,616 | SH |
| 14 | INSMED INC | INSM | 457669307 | $1.4M | 1.20% | 11,866 | SH |
| 15 | ALPINE INCOME PPTY TR INC | PINE | 02083X103 | $1.3M | 1.16% | 75,000 | SH |
| 16 | BUILDERS FIRSTSOURCE INC | BLDR | 12008R107 | $1.3M | 1.14% | 22,500 | SH |
| 17 | AXSOME THERAPEUTICS INC. | AXSM | 05464T104 | $1.2M | 1.11% | 6,752 | SH |
| 18 | JAZZ PHARMACEUTICALS PLC | JAZZ | G50871105 | $1.1M | 0.96% | 4,688 | SH |
| 19 | HALOZYME THERAPEUTICS INC | HALO | 40637H109 | $1.1M | 0.96% | 9,821 | SH |
| 20 | ASCENDIS PHARMA A/S | ASND | K08588103 | $1.1M | 0.95% | 4,706 | SH |
| 21 | AMGEN INC | AMGN | 031162100 | $1.0M | 0.92% | 2,455 | SH |
| 22 | CTO RLTY GROWTH INC NEW | CTO | 22948Q101 | $1.0M | 0.91% | 50,000 | SH |
| 23 | UNUSUAL MACHS INC | UMAC | 91532F102 | $979.2K | 0.87% | 40,000 | SH |
| 24 | ABBVIE INC | ABBV | 00287Y109 | $963.4K | 0.86% | 3,683 | SH |
| 25 | ISHARES TR | IYR | 464287739 | $950.4K | 0.84% | 10,000 | SH |
| 26 | RHYTHM PHARMACEUTICALS INC | RYTM | 76243J105 | $935.1K | 0.83% | 9,821 | SH |
| 27 | BIOGEN INC | BIIB | 09062X103 | $924.3K | 0.82% | 4,092 | SH |
| 28 | PERSONALIS INC | PSNL | 71535D106 | $909.3K | 0.81% | 55,854 | SH |
| 29 | SAUL CTRS INC | BFS | 804395101 | $902.4K | 0.80% | 30,000 | SH |
| 30 | PENNANTPARK INVTS CORP | PNNT | 708062104 | $891.0K | 0.79% | 270,000 | SH |
| 31 | ROCKWELL AUTOMATION INC | ROK | 773903109 | $870.7K | 0.77% | 2,000 | SH |
| 32 | TEMPUS AI INC | TEM | 88023B103 | $819.0K | 0.73% | 10,000 | SH |
| 33 | CENTERSPACE | CSR | 15202L107 | $816.0K | 0.72% | 15,000 | SH |
| 34 | J P MORGAN EXCHANGE TRADED F | BBJP | 46641Q217 | $780.5K | 0.69% | 9,943 | SH |
| 35 | XOMETRY INC | XMTR | 98423F109 | $771.4K | 0.68% | 7,500 | SH |
| 36 | ASML HLDG NV | ASML | N07059210 | $770.0K | 0.68% | 425 | SH |
| 37 | GLOBUS MED INC | GMED | 379577208 | $749.0K | 0.67% | 10,000 | SH |
| 38 | STEREOTAXIS INC | STXS | 85916J409 | $738.0K | 0.66% | 600,000 | SH |
| 39 | SYMBOTIC INC | SYM | 87151X101 | $736.2K | 0.65% | 17,500 | SH |
| 40 | ISHARES INC | EWA | 464286103 | $725.4K | 0.64% | 25,625 | SH |
| 41 | IONIS PHARMACEUTICALS INC | IONS | 462222100 | $721.7K | 0.64% | 16,163 | SH |
| 42 | INTUITIVE SURGICAL INC | ISRG | 46120E602 | $711.6K | 0.63% | 1,750 | SH |
| 43 | AEROVIRONMENT INC | AVAV | 008073108 | $711.1K | 0.63% | 5,000 | SH |
| 44 | MANHATTAN ASSOCIATES INC | MANH | 562750109 | $695.5K | 0.62% | 3,500 | SH |
| 45 | KRYSTAL BIOTECH INC | KRYS | 501147102 | $680.4K | 0.60% | 2,046 | SH |
| 46 | REDWIRE CORPORATION | RDW | 75776W103 | $678.6K | 0.60% | 65,000 | SH |
| 47 | EDGEWISE THERAPEUTICS INC | EWTX | 28036F105 | $672.8K | 0.60% | 16,572 | SH |
| 48 | ONDAS INC | ONDS | 68236H204 | $659.7K | 0.59% | 90,000 | SH |
| 49 | SYNOPSYS INC | SNPS | 871607107 | $652.4K | 0.58% | 1,500 | SH |
| 50 | BIONTECH SE | BNTX | 09075V102 | $643.6K | 0.57% | 6,547 | SH |
| Period | Filed | AUM | Holdings | Accession |
|---|---|---|---|---|
| 2026-09-30 | 2026-11-03 | $112.6M | 247 | 0001580642-26-007378 |
| 2026-06-30 | 2026-07-24 | $118.0M | 261 | 0001580642-26-004575 |
| 2026-03-31 | 2026-05-07 | $100.1M | 252 | 0001580642-26-003040 |
| 2025-12-31 | 2026-02-12 | $100.3M | 250 | 0001580642-26-001010 |
SAN JUAN 00912